Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nitric oxide as an antioxidant.

J Kanner1, S Harel, R Granit

  • 1Department of Food Science, Volcani Center, Bet Dagan, Israel.

Archives of Biochemistry and Biophysics
|August 15, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Teclistamab in Elderly Patients With Relapsed/Refractory Multiple Myeloma: A Subgroup Analysis of the French RetrosTECtive Cohort.

EJHaem·2026
Same author

Teclistamab for relapsed refractory multiple myeloma patients on dialysis.

British journal of haematology·2024
Same author

Plasma cell-directed therapies induce profound clinical and durable responses in patients with severe or relapsed/refractory scleromyxedema.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

French early nationwide idecabtagene vicleucel chimeric antigen receptor T-cell therapy experience in patients with relapsed/refractory multiple myeloma (FENIX): A real-world IFM study from the DESCAR-T registry.

British journal of haematology·2024
Same author

Rituximab with alkylating agent in anti-myelin-associated glycoprotein neuropathy: A retrospective study of 26 cases.

British journal of haematology·2024
Same author

Perioral skin thickening revealing AL amyloidosis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022

Nitric oxide inhibits the prooxidative reactions of ferrous complexes and myoglobin with hydrogen peroxide, preventing harmful lipid peroxidation. This discovery offers insights into protecting biological systems from oxidative damage.

Area of Science:

  • Biochemistry
  • Oxidative Stress Research

Background:

  • Ferrous complexes and myoglobin can react with hydrogen peroxide, generating reactive species that cause oxidative damage.
  • Lipid peroxidation is a key indicator of cellular damage mediated by reactive oxygen species.

Purpose of the Study:

  • To investigate the role of nitric oxide in modulating the reactivity of ferrous complexes and myoglobin with hydrogen peroxide.
  • To determine the effect of nitric oxide on Fenton reactions and myoglobin-mediated lipid peroxidation.

Main Methods:

  • Studied the interaction of ferrous complexes with hydrogen peroxide (Fenton reaction) in a nitrogen environment.
  • Investigated the effect of nitric oxide pretreatment on Fenton reactions and methionine oxidation.
  • Examined the interaction of various myoglobin forms (metmyoglobin, oxymyoglobin, nitric oxide-myoglobin) with hydrogen peroxide.

Related Experiment Videos

  • Measured spectral changes and lipid peroxidation (TBA-RS accumulation) in microsomes.

    • Main Results:

    • Nitric oxide inhibited benzoate monohydroxy compound formation in Fenton reactions and methionine oxidation.
    • Metmyoglobin and oxymyoglobin activated by H2O2 initiated membrane lipid peroxidation.
    • Nitric oxide-myoglobin, upon interaction with H2O2, formed metmyoglobin and did not significantly promote lipid peroxidation.

    Conclusions:

    • Nitric oxide liganded to ferrous complexes prevents their prooxidative reactions with hydrogen peroxide.
    • Nitric oxide-myoglobin is less susceptible to forming ferryl myoglobin, thus reducing its prooxidative potential compared to other myoglobin forms.